SCHEMBL2363134

SCHEMBL2363134

O=C(O)C(O)(CCCCCCCCCCCCCCCCO)CC(O)CO

nearest known ligand 0.38

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.38
ACACA Q13085 1/20 0.38
ARG2 P78540 1/20 0.35
GPR84 Q9NQS5 1/20 0.34
FFAR1 O14842 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34
ACLY P53396 11/20 0.34
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19990141 0.86 KDM4E (0.42) ACACBACACAGPR84FFAR1FFAR4
SCHEMBL851735 0.86 KDM4E (0.42) ACACBACACAGPR84FFAR1FFAR4
SCHEMBL3377620 0.79 ACACB (0.39) ACACBACACAARG2GPR84FFAR1
SCHEMBL7155871 0.76 ALDH1A1 (0.39) ACLYALDH1A1
SCHEMBL7149057 0.76 ALDH1A1 (0.39) ACLYALDH1A1
SCHEMBL10585526 0.76 ALDH1A1 (0.39) ACLYALDH1A1
SCHEMBL2925909 0.73 LMNA (0.52) CYP4F2CYP4A11ALDH1A1
SCHEMBL5574499 0.73 LMNA (0.52) CYP4F2CYP4A11ALDH1A1
SCHEMBL5574494 0.73 LMNA (0.52) CYP4F2CYP4A11ALDH1A1
SCHEMBL2925910 0.73 LMNA (0.52) CYP4F2CYP4A11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2347753-B1 Oral and tooth care and cleaning agents with alkylpyridine salts II HENKEL AG & CO KGAA (DE) 2016-12-28 EP claimed
CN-118019517-A Sun protection or daily care composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine and an inorganic UV filter 巴斯夫欧洲公司 2024-05-10 CN disclosed
CN-113710329-B Personal care compositions 高露洁-棕榄公司 2024-04-05 CN disclosed
CN-117396187-A Composition for administration in a body cavity comprising cannabidiol 融实医药(海南)有限公司 2024-01-12 CN disclosed
CN-112135668-B Oral care compositions comprising metal ions 宝洁公司 2024-01-02 CN disclosed
US-11793742-B2 Mixtures of cosmetic UV absorbers BASF SE (DE) 2023-10-24 US disclosed
CN-116075291-A Method for preventing or reducing hair from falling 联合利华知识产权控股有限公司 2023-05-05 CN disclosed
EP-3191075-B1 MIXTURES OF COSMETIC UV ABSORBERS BASF SE (DE) 2023-02-15 EP disclosed
EP-3523350-B1 ULTRAVIOLET RADIATION ABSORBING POLYMER COMPOSITION BASF SE (DE) 2022-12-07 EP disclosed
CN-115227593-A Sunscreen formulations optimized for vitamin D formation 巴斯夫欧洲公司 2022-10-25 CN disclosed
WO-2006040048-A1 ACIDIC AND BUFFERED SKIN-CARE COMPOSITIONS COMPRISING NICOTINAMID AND AN ABSORBING AGENT BAYER CONSUMER CARE AG (CH) 2006-04-20 WO disclosed
US-20050058610-A1 Cosmetic mixtures containing ultraviolet radiation absorber and decoloring agents CIBA SPECIALTY CHEMICALS CORP. 2005-03-17 US disclosed
WO-2005013931-A1 USE OF HALOGENATED HYDROXYDIPHENYL ETHER COMPOUNDS FOR THE TREATMENT OF THE SKIN CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-02-17 WO disclosed
US-20040265248-A1 Biphenylene compounds CIBA SPECIALTY CHEMICALS CORP. 2004-12-30 US disclosed
US-20040242579-A1 Triazine derivatives and their use as sunscreens CIBA SPECIALTY CHEMICALS CORP. 2004-12-02 US disclosed
EP-1432400-A1 USE OF GUAIOL FOR TREATING THE SKIN Ciba SC Holding AG (CH) 2004-06-30 EP disclosed
EP-1417886-A1 Substituted phenols as useful repellents for insects Ciba SC Holding AG (CH) 2004-05-12 EP disclosed
EP-1378231-A1 Formulation of UV absorbers by incorporation in solid lipid nanoparticles Ciba Specialty Chemicals Holding Inc. (CH) 2004-01-07 EP disclosed
US-20030235540-A1 Formulation of UV absorbers by incorporation in solid lipid nanoparticles CIBA SPECIALTY CHEMICALS CORP. 2003-12-25 US disclosed
WO-2003024417-A1 USE OF GUAIOL FOR TREATING THE SKIN CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030235540-A1 Formulation of UV absorbers by incorporation in solid lipid nanoparticles CUTA, LIPC, AUP1 ACACB 38/4885ACACA 114/4885ARG2 2432/4885
US-20050058610-A1 Cosmetic mixtures containing ultraviolet radiation absorber and decoloring agents TYR, MC1R, UNG ACACB 997/4885ACACA 1448/4885ARG2 1537/4885
US-20040242579-A1 Triazine derivatives and their use as sunscreens CBR1, CBR3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 ACACB 977/4885ACACA 480/4885ARG2 1173/4885
US-11793742-B2 Mixtures of cosmetic UV absorbers BTD, TMSB10, TH ACACB 3450/4885ACACA 4092/4885ARG2 4729/4885
US-20040265248-A1 Biphenylene compounds AHR, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 ACACB 1583/4885ACACA 1051/4885ARG2 1618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.